XAnge

Managing Partner Cyril Bertrand leads the investment committee alongside Partner Nadja Bresous Mehigan. The partnership group makes collectively approved deployment decisions, with thematic emphasis determined by XAnge Innovation, the in-house research unit that publishes sector maps before committing capital. No single family office backer holds veto authority over individual investments, preserving the professional manager structure.

The firm is anchored by Groupe Caisse des Dépôts, the historic French sovereign development institution, alongside several undisclosed European industrial families. The structure operates as a pooled multi-family office fund — individual family investors commit to a fund vehicle rather than co-investing deal by deal, which provides XAnge with committed capital pools for sequence investing.

XAnge primarily writes Seed and Series A checks, with occasional Series B participation for existing portfolio companies. The firm prefers initial commitments in the €2M–€15M range, with material follow-on reserves — typically reserving 40–50% of fund capital for subsequent rounds. The focus is continental Europe, weighted toward France and the DACH region.

XAnge operates as a hybrid: it is a professionally managed venture fund whose limited partners are predominantly family offices rather than institutional allocators. The firm's origins trace to La Poste's in-house venture arm, but it now functions independently with a pooled multi-family office structure. This means portfolio companies engage with a conventional VC fund, while the LP base enjoys family-office-style discretion.

Consumer internet and biotech/pharma are notably absent from XAnge's public portfolio. The firm concentrates on B2B enterprise software, fintech, digital health, climate tech, and selected deep tech verticals. Hard science investments requiring FDA approval or lengthy drug-development timelines fall outside the partnership's stated expertise and deployment window.

No philanthropic foundation or donor-advised structure is publicly disclosed by XAnge itself. Individual family office LPs may operate their own philanthropic vehicles, but these are structurally separate from the fund management entity. XAnge's mandate is exclusively for-profit venture capital deployment.

XAnge Innovation, the firm's in-house research group, generates thematic maps of emerging European technology clusters and publishes findings before capital deployment begins. This pre-transaction research function creates lengthy lead times with founding teams and acts as a filtering mechanism — XAnge often meets companies 8-12 months before a funding round opens. The firm's presence in Paris, Berlin, and Munich creates regional coverage, while family office LP relationships occasionally surface deals from industrial family networks.